Events

Global Genes and the Foundation for Children with Atypical HUS (aHUS) invite individuals diagnosed with aHUS along with their families and caregivers to the Ohio Meetup to engage in informative conversations coupled with supportive networking. The aHUS Meetups provide a welcoming environment where attendees can learn more about this rare...
This summit will be discussing the issues and challenges the pharmaceutical industry is currently facing, pertaining to getting drugs to market. Attendee titles include the heads of clinical operations, trials, research, and project management, as well as vendor outsourcing. These attendees will be coming from mid-size Pharmaceutical, biopharma and biotech companies within the...
The ICORD 2014 Annual Meeting will be held on October 7-9, 2014 in Ede, The Netherlands. This year’s meeting will be entitled: “Societal value of Prevention, Diagnosis and Treatment of Rare Diseases” The overall aim of the ICORD meeting is to continue developing the constructive international partnership that will globally result...
GTCbio would like to invite you to attend our Biomarker Europe Summit 2014 on October 9th-10th in Dublin, Ireland. The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies,...
GTCbio is delighted to present the Protein Discovery Summit 2014 to be held on October 23-24, 2014 in Boston, MA. This summit covers major hot topics in the field that split into four parallel conferences. Areas of discussion include novel techniques, new algorithms and databases for PPIs, and potential druggable...
The Male Cancer Research & Drug Discovery conference offers a unique mix of engaging sessions and topics focused on the research and drug discovery of male specific oncology. The conference includes keynote addresses from representatives from big pharma, academic institutions and government research labs who will present data and case studies...
2014 FOD/OAA National Metabolic Conference is for parents, family members, affected individuals, professionals and exhibitors that have an interest in Metabolic Disorders. It is only through generous donations and sponsorships that the FOD Group and OAA are able to offer such an important opportunity every two years to Families and...
When Britain launched the Early Access to Medicines Initiative in March this year it aimed to accelerate the access to drugs for patients with rare diseases. This key implementation is not only extremely beneficial for patients but it is also going to open up the market and allow pharmaceutical companies to develop further. Based on...
GTC’s 9th Cell Based Assay & Screening Technologies Conference  will be held on October 7-8, 2014 in Dublin, Ireland. Over the past years, the field of assay technologies, laboratory automation, and informatics has taken great leaps forward. Present demands from the drug discovery process have propelled a shift in focus from high...
GTCbio’s 7th Imaging in Drug Discovery Conference, to be held October 7-8, 2014 in Dublin, Ireland. Imaging has long been a powerful tool in the drug discovery process, and we invite you to join us as we continue to discuss how imaging technologies can be better translated from pre-clinical to clinical studies.  This...
If you are looking at profiling and associating your organization to a high-quality program, you should not miss the third Orphan Drugs Summit, an excellent platform to have face-to-face contact and initiate new business relationships with senior orphan drug professionals. 115 C-level, scientific and senior orphan drugs’ professionals from pharma and...
GTC welcome you to the Antibody and Protein Therapeutics Conference being held on October 23-24, 2014 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss opportunities and challenges involved in...
GTC’s 11th Anti-infectives Partnering and Deal-Making Conference, taking place on July 10-11, 2014 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities...
The 5th annual World Orphan Drug Congress Europe is the region’s largest event that delivers solutions to the industry’s most pressing issues around Clinical Development, Market Access, Pricing and Reimbursement, Patient Advocacy and Corporate Development. The congress is a one-stop shop for the industry’s complete value chain. A keynote conference,...
This summit includes two parallel conferences focused on the research and drug discovery of female specific and male specific oncology. Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as breast cancer diagnostics and therapeutics, prostate cancer diagnostics and...
We are excited to announce the 7th CNS Partnering & Deal-Making Conference, to be held September 18-19, 2014 in San Francisco, CA. Over the past years, this partnering and business development conference has given global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as...
The 5th US-EU Conference on Repair of Endogenous DNA Damage will focus on the DNA repair responses to naturally formed genomic damage, and the relationship of defects in these responses to genetically inherited disorders associated with cancer predisposition, neurological deficits and premature aging. Understanding the contributions of endogenous DNA damage...
Wednesday, October 22, 2014 – Thursday, October 23, 2014 Kauai, HA   The goals of the 2014 Meeting of the Androgen Excess Society are to foster education, collaboration and dissemination of scientific findings, and develop projects in the arena of androgen excess.   Contact: Esther Eisenberg, M.D., M.P.H., (615) 479-7593, [email protected]  ...